Reports for SANDOZ IRBESARTAN HCT
Brand name
SANDOZ IRBESARTAN HCT
Company Name
SANDOZ CANADA INCORPORATED
|
Drug Identification Number
02337428 |
Ingredients
IRBESARTAN HYDROCHLOROTHIAZIDE |
Ingredient Strength
150 MG 12.5 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| SANDOZ IRBESARTAN HCT | 100 | Resolved | 2019-01-21 | 2020-07-20 | 73141 |
| SANDOZ IRBESARTAN HCT | 500 | Resolved | 2019-01-21 | 2020-07-20 | 73144 |
| SANDOZ IRBESARTAN HCT | 100FCT BO CA | Resolved | 2020-09-21 | 2020-10-27 | 124600 |
| SANDOZ IRBESARTAN HCT | 500FCT BO CA | Resolved | 2020-09-21 | 2020-10-27 | 124606 |
| SANDOZ IRBESARTAN HCT | 500 FCT BO | Resolved | 2020-11-27 | 2020-12-09 | 129102 |
| SANDOZ IRBESARTAN HCT | 500FCT BO CA | Actual shortage | 2021-01-12 | 2021-01-12 | 131394 |
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|